A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease
Clinical trial NCT03412006 · COMPLETED
Trial details
- NCT number
- NCT03412006
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-02
- Primary completion
- 2019-10-02
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.